๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Cutaneous Squamous Cell Carcinoma

Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma NCT06606028n/a1 site๐Ÿ“ San Francisco University of California, San Francisco ยท Tests: Blood Specimen Collection, Tumor Tissue Collection, Medical Record Review A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Whittier Daiichi Sankyo ยท Tests: Ifinatamab deruxtecan Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma NCT06567314Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Ivonescimab Towards Cure Via Only Ultra-short ICB in CSCC NCT06823479Phase 25 sites๐Ÿ“ Maastricht๐Ÿ“ Amsterdam๐Ÿ“ Amsterdam The Netherlands Cancer Institute ยท Tests: Nivolumab, Ipilumimab A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors NCT07115043Phase 1, Phase 213 sites๐Ÿ“ Grand Rapids๐Ÿ“ St Louis๐Ÿ“ Pittsburgh AstraZeneca ยท Tests: AZD6750, rilvegostomig TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer NCT06868433Phase 12 sites๐Ÿ“ Atlanta๐Ÿ“ Atlanta Emory University ยท Tests: Autologous Tumor Membrane Vesicles Vaccine, Biospecimen Collection, Computed Tomography, Echocardiography, Magnetic Resโ€ฆ Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy NCT07426484Phase 42 sites๐Ÿ“ Boston๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Cosibelimab, Prednisone, Sirolimus, Everolimus A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies NCT05669430Phase 1, Phase 213 sites๐Ÿ“ Los Angeles๐Ÿ“ Denver๐Ÿ“ New Haven GV20 Therapeutics ยท Tests: GV20-0251, GV20-0251, GV20-0251 and Pembrolizumab [KEYTRUDAยฎ], GV20-0251 and Pembrolizumab [KEYTRUDAยฎ] Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System NCT07042295Phase 255 sites๐Ÿ“ Birmingham๐Ÿ“ Gilbert๐Ÿ“ La Jolla National Cancer Institute (NCI) ยท Tests: Amivantamab and Recombinant Human Hyaluronidase, Biospecimen Collection, Cetuximab, Computed Tomography, Magnetic Resonโ€ฆ SUV PDL1/PD1 in Sun Damaged & Sun Protected Human Skin of Participants NCT06177106NA1 site๐Ÿ“ Tucson University of Arizona ยท Tests: Solar Simulated Light Skin Cancer and Hyperthermia and Radiotherapy NCT06384053NA4 sites๐Ÿ“ Aarau๐Ÿ“ Winterthur๐Ÿ“ Bern Kantonsspital Winterthur KSW ยท Tests: Water-filtered infrared-A-hyperthermia (wIRA) hyperthermia combined, Radiotherapy (RT) TIL Therapy in cSCC and MCC NCT07288073Phase 21 site๐Ÿ“ Boston Karam Khaddour, MD, MS ยท Tests: LN-145, Cyclophosphamide, Fludarabine, Interleukin-2 Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies NCT07682831NA1 site๐Ÿ“ Victor University of Rochester ยท Tests: Two photon microscopy imaging A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors NCT07600476Phase 13 sites๐Ÿ“ Munich๐Ÿ“ Wรผrzburg๐Ÿ“ Mรผnster Kupando GmbH ยท Tests: KUP-101A L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma NCT07228442Phase 219 sites๐Ÿ“ Orange๐Ÿ“ Atlanta๐Ÿ“ Boston Philogen S.p.A. ยท Tests: L19IL2/L19TNF Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rฮฑ Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer NCT05267626Phase 1, Phase 217 sites๐Ÿ“ Miami๐Ÿ“ Grand Rapids๐Ÿ“ Minneapolis Aulos Bioscience, Inc. ยท Tests: AU-007, Aldesleukin, Avelumab, Nivolumab MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors NCT05076760Phase 12 sites๐Ÿ“ Tampa๐Ÿ“ Durham Memgen, Inc. ยท Tests: MEM-288 Intratumoral Injection, Nivolumab, Docetaxel (89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma NCT05747625Phase 11 site๐Ÿ“ Nashville Eben Rosenthal ยท Tests: Panitumumab, Zirconium Zr 89 Panitumumab, Positron Emission Tomography, Computed Tomography, Electronic Health Record Rโ€ฆ Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma NCT06288191Phase 21 site๐Ÿ“ Wollstonecraft Melanoma Institute Australia ยท Tests: Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program NCT06265285Phase 21 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Home Health Encounter, Nivolumab, Patient Monitoring, Questionnaire Administration Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer NCT05896839Phase 1, Phase 226 sites๐Ÿ“ La Jolla๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles National Cancer Institute (NCI) ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ipilimumab, Kidney Biopsy Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC) NCT05377905Phase 1, Phase 21 site๐Ÿ“ Pittsburgh Falo, Louis, MD ยท Tests: Microneedle Array Doxorubicin (MNA-D) Stereotactic Post-operative Radiotherapy for Intraparotid Metastatic Cutaneous Squamous Cell Carcinoma NCT07337161NA1 site๐Ÿ“ London David Palma ยท Tests: SBRT, Standard Radiation Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors NCT04119024Phase 13 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ Stanford Anusha Kalbasi ยท Tests: Biopsy, Biospecimen Collection, Computed Tomography, Cyclophosphamide, Fludarabine Phosphate Cutaneous Squamous Cell Carcinoma Staging Study NCT05695222n/a2 sites๐Ÿ“ London๐Ÿ“ London Queen Mary University of London ยท Tests: This is not an interventional study Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC NCT05085496Phase 11 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Atezolizumab, Stereotactic Body Radiation Therapy ctDNA in Cutaneous Squamous Cell Carcinoma NCT06875609n/a1 site๐Ÿ“ Boston Massachusetts Eye and Ear Infirmary ยท Tests: Blood and Tissue Collection Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation NCT06662058NA1 site๐Ÿ“ Atlanta Emory University ยท Tests: Audiometric Test, Audiometric Test, Audiometric Test, Interview IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel, Capivasertib Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study NCT07215988n/a1 site๐Ÿ“ Columbus Ohio State University Comprehensive Cancer Center ยท Tests: Non-Interventional Study
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy